Tag: Diabetes: Type II
Metformin After Induction Tx May Preserve Beta-Cell Function
Also associated with better glycemic control than repeat intensive insulin therapy after induction IIT
Greater Weight Loss With RYGB in Obese With T2DM at Three Years
Lasting improvements in weight, HbA1c, cardiovascular risk vs. intensive weight management
Eating Slower Tied to Lower Obesity Risk in Type 2 Diabetes
Slower eating also found to be associated with reduced BMI, waist circumference
Diabetes Signs May Be Present 20 Years Before Diagnosis
Subtle elevations in fasting glucose and triglycerides associated with developing type 2 diabetes
Diabetes Consultation Model Helps Patient Involvement in Care
Majority of patients reported shared decision making; they felt more involved and it was widely appreciated
Interactive Simulation Can Affect Activity Intentions in T2DM
Increased participant intentions to exercise with walking a week after completing intervention
Increased Long-Term Mortality for All Weight Categories in T2DM
Nadir at BMI of 25 to <30 kg/m²; stepwise increase to peak for patients with BMI ≥40 kg/m²
Intensive Lifestyle Intervention Linked to Cerebral Blood Flow
In obese, overweight adults with T2DM, long-term weight loss intervention tied to greater blood flow
Pioglitazone Associated With Lower Blood Leptin in Diabetes
In T2DM, leptin levels are lower with pioglitazone than placebo but not oral antidiabetic drugs
DPP-4 Inhibitor Has Dissociated Effects on β-Cell Function
Single dose of sitagliptin linked to increases in standardized insulin secretion, active GIP, GLP-1